News and Trends 13 Jul 2020 Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal …Kiadis’ CEO Arthur Lahr told me that antibody drugs can be made to mark cancer cells. Natural killer cells then swoop in, recognize the antibodies, and kill the marked tumor… July 13, 2020 - 3 minutesmins - By David Wilson Share WhatsApp Twitter Linkedin Email
In Depth 26 Nov 2025 Beyond GLP-1s: is there a new wave of metabolic disease treatments? …patients, there’s another underlying driver of their disease that they’re not aware of.” Jacks compared this feeling to swimming upstream against an invisible current. “They don’t know it, and they don’t realize that there’s something that’s making it very… November 26, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2025 3 promising biotech approaches to treat Hunter syndrome, a rare genetic disorder …been engineered to bind to the transferrin receptor – a natural transport receptor that helps cells absorb iron from transferrin, a protein that carries iron throughout the body – which… February 20, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jan 2023 Psoriasis drug may help treat type 1 diabetes …over time we can investigate certain immunological patterns or cell types in the blood that can be used to identify patient groups that respond best to the treatment,” Lind concluded…. January 27, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Mar 2018 Early Research in Bone Marrow Transplants Could Treat ALS …bone marrow has the advantage that there is less risk of an immune response against the patient’s own cells. Importantly, the treatment method allows for the amount of transplanted cells… March 19, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 9 Nov 2017 Doctors Use Genetically Modified Stem Cells to Give a Boy New Skin …transplant, Hassan’s condition began to improve as the cells stably expressed the missing gene. This highlights the huge potential that this approach has for the treatment of epidermolysis bullosa and… November 9, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jun 2023 Anocca raises $36.6M for large-scale development of cancer cell therapies …engineered in the laboratory to express the desired TCR. These cells are then re-infused as a treatment. This T-cell therapy modality is called TCR-T. There are several TCR-Ts under development… June 2, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Feb 2017 CEVEC is Transforming Vaccine Development starting with Zika …virus-producing cell lines CAP-GT, CEVEC is making significant contributions to the development of safer vectors for gene therapy. Now they are planning to enter the vaccine market. The Zika virus… February 20, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
More News! 28 Oct 2022 ‘Dark matter’ creates a whole new level of cancer gene activity in tumors, researchers say …could change the way cancer is thought about and the way it is treated – and lead to new forms of tests that predict cancer’s behavior more accurately. The chemical… October 28, 2022 - 6 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 19 Nov 2018 Silk Biomaterial Could Regenerate the Brain After a Stroke …promote regeneration of the brain by reducing the extent of the damage and promoting the remodeling of the brain. However, most of the cells don’t survive the procedure due to… November 19, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 9 Apr 2019 Beyond the Lab-Grown Burger: ‘Cellular Agriculture’ is Taking Over the Food Industry …common animal these emerging companies are trying to replace; it is known for being the most inefficient meat to produce and one of the biggest contributors to global warming. But… April 9, 2019 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Oct 2024 Six biotech companies advancing multiple sclerosis therapies …currently in phase 2 of development. BTK is a non-receptor tyrosine kinase that regulates the development and signaling of B cells and myeloid cells that are thought to contribute to… October 24, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email